The results exhibited that DADS treatment reduced the POU2F1 protein levels in both untreated CRC and 3-MA-treated CRC cells, but not in the MG132-treated CRC cells (Figure 5C). The gene discussed is POU2F1; the disease is colorectal carcinoma.